Course

The Pathophysiology of Systemic Lupus Erythematosus: A Nursing Primer

We will provide an introductory level description of the basic immunology and pathophysiology of systemic lupus erythematosus (SLE) that will allow rheumatology nurses and nurse practitioners to better understand and explain key concepts of SLE to their patients.

0 out of 5 steps completed0%
0 Lessons

The Pathophysiology of Systemic Lupus Erythematosus: A Nursing Primer

PROVIDED BY

Support for this activity has been made possible through an educational grant from GSK

TARGET AUDIENCE

This activity has been designed to meet the educational needs of nurses and nurse practitioners. Other healthcare providers may also participate.

ACTIVITY DESCRIPTION

In this issue of Rheumatology Nurse Practice, we will provide an introductory level description of the basic immunology and pathophysiology of systemic lupus erythematosus (SLE) that will allow rheumatology nurses and nurse practitioners to better understand and explain key concepts of SLE to their patients.

LEARNING OBJECTIVES

After participating in the activity, learners should be better able to:

  • Identify at least three genetic, environmental, and hormonal risk factors that have been tied to an increased risk of developing SLE
  • Discuss the primary immunologic events that set in motion the development and progression of SLE
  • Differentiate the manifestations of the three types of skin diseases that are specific to SLE
  • Develop strategies to appropriately transmit the seriousness of an SLE diagnosis to patients and their families in a manner that promotes adherence and overall cooperation with long-term disease management

DISCLOSURE STATEMENT

According to the disclosure policy of the Rheumatology Nurses Society, all faculty, planning committee members, editors, managers and other individuals who are in a position to control content are required to disclose any relevant relationships with any commercial interests related to this activity. The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation. All educational materials are reviewed for fair balance, scientific objectivity and levels of evidence.

RELATIONSHIPS ARE ABBREVIATED AS FOLLOWS

E: Educational planning committee
G: Grant/research support recipient
A: Advisor/review panel member
C: Consultant
S: Stock shareholder
SB: Speaker bureau
PE: Promotional event talks
H: Honoraria
O: Other

DISCLOSURES AS FOLLOWS

Linda Grinnell-Merrick, MS, NP-BC, has disclosed the following relevant financial relationships specific to the subject matter of the content included in this educational activity: Pfizer, Novartis, Lilly, Horizon/A; Janssen/C, SB; AbbVie, Celgene/SB.

Monica Richey, MSN, ANP-CP/GNP, has disclosed the following relevant financial relationships specific to the subject matter of the content included in this educational activity: Mallinckrodt/A.

Iris Zink, MSN, NP, RN-BC, has disclosed the following relevant financial relationships specific to the subject matter of the content included in this educational activity: AbbVie, Pfizer, Crescendo/A,SB; Sanofi/A; Bristol Myers-Squibb/SB.

Cathy Patty-Resk, MSN, RN, CPNP-PC, has disclosed the following relevant financial relationships specific to the subject matter of the content included in this educational activity: Horizon, Novartis, Medac/A.

INDEPENDENT CLINICAL PEER REVIEWER

Carrie Beach, RN, BSN, Rheumatology Nurse, Columbus (OH) Arthritis Center has disclosed the following relationships: Pfizer, Horizon, Novartis/A.

OFF-LABEL PRODUCT DISCLOSURE

This activity will review off-label or investigational information of the following: Atacicept, blisibimod, anifrolumab, and sifalimumab.

PLANNING COMMITTEE

Kim Cheramie, MSN, RN-BC, Lead Nurse Planner, Rheumatology Nurses Society, has disclosed that she does not have any relevant financial relationships specific to the subject matter of the content of the activity.

Scott Kober, MBA, President, MedCaseWriter, has disclosed that he does not have any relevant financial relationships specific to the subject matter of the content of the activity.

Kathy Holliman, Medical Writer, has disclosed that she does not have any relevant financial relationships specific to the subject matter of the content of the activity.

Kevin D. Lyons, Executive Director of the Rheumatology Nurses Society and Chief Executive Officer of Lyons Den Solutions, LLC, has disclosed that he does not have any relevant financial relationships specific to the subject matter of the content of the activity.

ACCREDITATION AND CREDIT DESIGNATION

Nurses

Rheumatology Nurses Society is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Rheumatology Nurses Society designates this educational activity for 1.75 contact hours (1.0 pharmacotherapeutic contact hours).

METHOD OF PARTICIPATION

There are no fees to participate in the activity. Participants must review the activity information including the learning objectives and disclosure statements, as well as the content of the activity. To receive CNE credit for your participation, please complete the post-test (achieving a passing grade of 70% or greater), and program evaluation. Your certificate can be printed immediately.

COPYRIGHT

© 2017. This CNE-certified activity is held as copyrighted © by Rheumatology Nurses Society. Through this notice, the Rheumatology Nurses Society grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).